A Safety Study Assessing Oral Anticoagulation with Apixaban versus Vitamin-K Antagonists in Patients with Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment (AXADIA)

Basic data for this project

Type of project: Individual project

Duration at the University of Münster: 01/04/2017 - 01/02/2019

Description

Keywords: Klinische Studie; chronischem Nierenversagen

Funder / funding scheme:

Wirtschaft

Project management at the University of Münster

Reinecke, Holger

Klinik für Kardiologie I

Applicants from the University of Münster

Reinecke, Holger

Klinik für Kardiologie I

Research associates from the University of Münster

Gerß, Joachim

Institute of Biostatistics and Clinical Research (IBKF)

Publications of the University of Münster resulting from the project

A Randomized Controlled Trial Comparing Apixaban With the Vitamin K Antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 Study

Reinecke, H; Engelbertz, C; Bauersachs, R; Breithardt, G; Echterhoff, HH; Gerß, J; Haeusler, KG; Hewing, B; Hoyer, J; Juergensmeyer, S; Klingenheben, T; Knapp, G; Christian Rump, L; Schmidt-Guertler, H; Wanner, C; Kirchhof, P; Goerlich, D (2023)

In: Circulation, 147(4), 296-309. doi:10.1161/CIRCULATIONAHA.122.062779

Research article (journal) | Peer reviewed | Published